Xiaoming Yang

Xiaoming Yang


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2015 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
ZLZhiming Li
Zhiming Li
JSJihong Sun
Jihong Sun
XHXi Hu
Xi Hu
NHNing Huang
Ning Huang
GHGuocan Han
Guocan Han
XYXiaoming Yang
Xiaoming Yang
Purpose: To evaluate the possibility of using a variable flip angle (VFA) T1 mapping technique to diagnose liver fibrosis.Materials and Methods: Liver fibrosis was induced in rabbits by repetitive administration of carbon tetrachloride (CCl4). T1‐weighted magnetic resonance imaging (MRI) was performed in 29 animals (liver fibrosis, n = 18; control, n = 11) using a series of nonenhanced liver acquisition volume acceleration (LAVA) with VFAs at 3.0T. Hepatic T1 relaxation times were measured via regions of interest, which were correlated with subsequent histologic confirmation. The results of T1 mapping in assessment of liver fibrosis were compared with that of apparent diffusion coefficient (ADC) values.Results: The mean T1 relaxation time of the control group was the lowest (250.07 ± 88.12 msec), followed by the nonadvanced fibrosis group (387.83 ± 166.58 msec) and the advanced fibrosis group (496.90 ± 291.24 msec). T1 relaxation time measurements differed significantly between the liver fibrosis group and control group (P < 0.05), with a trend of increased mean T1 relaxation times as the fibrotic stage increased. Statistically significant differences were observed between the control group and the nonadvanced fibrosis group (P < 0.05), however with much overlap between the less severe stages. In discriminating between the control group and liver fibrosis group, stage F0‐1 (control and stage F1) and stage F2‐3, stage F0‐2 (control and stage F1‐2) and stage F3, area under the receiver operating characteristic (ROC) curves were 0.803 (cutoff value 273.01 msec), 0.712 (cutoff value 371.54 msec), and 0.696 (cutoff value 276.99 msec), respectively. No difference was found between T1 relaxation times and ADC values in assessment of liver fibrosis in our study.Conclusion: VFA T1 mapping may become a noninvasive imaging tool for the diagnosis of liver fibrosis. J. MAGN. RESON. IMAGING 2016;43:698–703.

1 May 2007 in Radiology
Verified
Journal Article
Closed access
XYXiaoming Yang
Xiaoming Yang
The rapid progress of nanoscience and the application of nanotechnology are changing the foundations of diagnosis, treatment, and prevention of cardiovascular diseases. As the core of nanotechnology, nano- and microparticles offer "three-in-one" functions as imaging agents, target probes, and therapeutic carriers. While nano- and microparticle-based imaging of cardiovascular interventions is still in its developing phase, it has already presented the exciting potential to monitor primary interventional procedures for precise therapeutic delivery, enhance the effectiveness of delivered therapeutics, and monitor therapeutic efficiency after interventions performed to treat cardiovascular diseases. This article provides an overview of the current status of the application of nano- and microparticles in the imaging of cardiovascular interventions.

1 February 2014 in Radiology
Verified
Journal Article
Closed access
FZFeng Zhang
Feng Zhang
TLThomas Le
Thomas Le
XWXia Wu
Xia Wu
HWHan Wang
Han Wang
TZTong Zhang
Tong Zhang
XYXiaoming Yang
Xiaoming Yang
We used the MR imaging heating guidewire to create localized hyperthermia in cholangiocarcinoma xenografts in mice and to target the common bile duct (CBD) walls in pigs to enhance chemotherapy, thus providing substantial localized therapeutic hyperthermia and preventing injury to the normal CBD and adjacent structures. PurposeTo determine whether magnetic resonance (MR) imaging heating guidewire–mediated radiofrequency (RF) hyperthermia could enhance the therapeutic effect of gemcitabine and 5-fluorouracil (5-FU) in a cholangiocarcinoma cell line and local deposit doses of chemotherapeutic drugs in swine common bile duct (CBD) walls.Materials and MethodsThe animal protocol was approved by the institutional animal care and use committee. Green fluorescent protein–labeled human cholangiocarcinoma cells and cholangiocarcinomas in 24 mice were treated with (a) combination therapy with chemotherapy (gemcitabine and 5-FU) plus RF hyperthermia, (b) chemotherapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline. Cell proliferation was quantified, and tumor changes over time were monitored with 14.0-T MR imaging and optical imaging. To enable further validation of technical feasibility, intrabiliary local delivery of gemcitabine and 5-FU was performed by using a microporous balloon with (eight pigs) or without (ei...

28 December 2015 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
ZLZhiming Li
Zhiming Li
JSJihong Sun
Jihong Sun
LCLumin Chen
Lumin Chen
NHNing Huang
Ning Huang
PHPeng Hu
Peng Hu
XYXiaoming Yang
Xiaoming Yang
Purpose: To evaluate the pharmacokinetic parameters of dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) in diagnosing and staging liver fibrosis in rabbits.Materials and Methods: DCE‐MRI with gadodiamide (Gd‐DTPA‐BMA) was performed on a 3.0 Tesla, 60 cm bore MR scanner for rabbits with CCl4‐induced liver fibrosis, and an untreated control group. Fibrosis was staged according to the METAVIR system: control (F0; n = 13), nonadvanced fibrosis (F1–2; n = 15), and advanced fibrosis (F3–4; n = 12). The DCE‐MRI parameters Ktrans, kep, Ve, and vp were measured with a dual‐input extended Tofts model. Receiver operating characteristic analyses were performed to assess the diagnostic performance of Ktrans, Ve, and vp in staging liver fibrosis.Results: Both Ktrans and Ve decreased with increasing fibrosis stage. Ktrans of the control group was significantly different from that of the overall fibrosis group, nonadvanced group, and advanced group (P < 0.001 for all). Significant differences were found between Ve of the control group and that of the overall fibrosis and advanced groups (P = 0.019 and P = 0.009, respectively). For Ktrans, the areas under the receiver operating characteristic curve (AUROCs) for discriminating the control group from the overall fibrosis and advanced fibrosis groups were 0.909 (95% confidence interval [CI], 0.809–1.000), and 0.936 (95% CI,0.847–1.000), respectively. For discriminating between the control and nonadvanced fibrosis groups, the AUROC of Ktrans was 0.887 (95% CI, 0.762–1.000). The AUROCs of Ktrans were higher than those of Ve and vp for discriminating between the control and overall fibrosis groups, the control and nonadvanced fibrosis groups, and the control and advanced fibrosis groups. Pharmacokinetic parameters were negatively correlated with fibrosis stage (Ktrans, rho = ‐0.668, P < 0.001; Ve, rho = ‐0.438, P = 0.005; vp, rho = ‐0.360, P = 0.023).Conclusion: Among pharmacokinetic parameters of DCE‐MRI in our study, Ktrans was an excellent predictor for differentiating fibrotic livers from normal livers, and differentiating normal livers from nonadvanced or advanced fibrosis livers. J. Magn. Reson. Imaging 2016;44:98–104.

21 May 2010 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
BQBensheng Qiu
Bensheng Qiu
DXDaohai Xie
Daohai Xie
Piotr WalczakPiotr Walczak
Piotr Walczak
XLXubin Li
Xubin Li
Jesús Ruiz-CabelloJesús Ruiz-Cabello
Jesús Ruiz-Cabello
XYXiaoming Yang
Xiaoming Yang
The purpose of this study was to develop an instant MR cell labeling technique, called magnetosonoporation. First, a magnetosonoporation apparatus was successfully established for MR labeling of stem cells. Then, the safety of this new cell labeling approach was confirmed by evaluation of cell viability, proliferation, and differentiation of magnetosonoporation‐labeled and unlabeled C17.2 neural stem cells. Subsequently, the feasibility of using in vivo MRI to detect magnetosonoporation/Feridex‐labeled stem cells was validated in living animals and confirmed by histologic correlation. The magnetosonoporation technique is expected to be convenient, efficient, and safe for future clinical application of MRI‐guided cell therapies. Magn Reson Med 63:1437–1441, 2010.

1 March 2010 in Radiology
Verified
Journal Article
Closed access
XYXiaoming Yang
Xiaoming Yang
Interventional molecular imaging can serve as one of the important approaches for bringing molecular imaging from benches and small-animal laboratories to large-animal suites, and, ultimately, to certain clinical applications in humans. Recent common interest in molecular imaging among both diagnostic and interventional radiologists has led to the establishment of a concept that could be called interventional molecular imaging. This concept, by combining interventional radiology with molecular imaging, is aiming to fully apply the advantages of both imaging fields. Interventional radiology can extend the capabilities of currently available molecular imaging techniques to (a) reach deep-seated targets, (b) enable a close look at small targets, (c) precisely guide delivery of nontargeted imaging tracers or therapeutic agents, and (d) superselectively enhance the effectiveness of targeted imaging and treatment. Interventional molecular imaging is becoming one of the frameworks for bringing molecular imaging from benches and small-animal laboratories to large-animal suites and, ultimately, to certain clinical applications in humans.© RSNA, 2010